Abstract
Rocky Mountain spotted fever (RMSF) is a severe illness caused by Rickettsia rickettsii for which there is no available vaccine. We hypothesize that exposure to the highly prevalent, relatively nonpathogenic "Rickettsia amblyommii" protects against R. rickettsii challenge. To test this hypothesis, guinea pigs were inoculated with "R. amblyommii." After inoculation, the animals showed no signs of illness. When later challenged with lethal doses of R. rickettsii, those previously exposed to "R. amblyommii" remained well, whereas unimmunized controls developed severe illness and died. We conclude that "R. amblyommii" induces an immune response that protects from illness and death in the guinea pig model of RMSF. These results provide a basis for exploring the use of low-virulence rickettsiae as a platform to develop live attenuated vaccine candidates to prevent severe rickettsioses.
Original language | English (US) |
---|---|
Pages (from-to) | 557-562 |
Number of pages | 6 |
Journal | Vector-Borne and Zoonotic Diseases |
Volume | 14 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1 2014 |
Keywords
- "Rickettsia amblyommii"
- Cross protection
- Rickettsia rickettsia
- Rocky Mountain spotted fever
ASJC Scopus subject areas
- Microbiology
- Infectious Diseases
- Virology